There are 2789 resources available
Introduction by the Chair
Presenter: Pasi Jänne
Session: Keynote lecture: Population risk stratification for early detection and personalized breast cancer treatment
Resources:
Slides
Webcast
Population risk stratification for early detection and personalized breast cancer treatment
Presenter: Olufunmilayo Olopade
Session: Keynote lecture: Population risk stratification for early detection and personalized breast cancer treatment
Resources:
Slides
Webcast
1560O_PR - Prevalence and impact of COVID-19 sequelae on treatment pathways and survival of cancer patients who recovered from SARS-CoV-2 infection
Presenter: Alessio Cortellini
Session: Proffered Paper session - SARS-CoV-2 and cancer
Resources:
Abstract
Slides
Webcast
1097O - The AXINET trial (GETNE1107): Axitinib plus octreotide LAR improves PFS by blinded central radiological assessment vs placebo plus octreotide LAR in G1-2 extrapancreatic NETs
Presenter: Rocio Garcia-Carbonero
Session: Proffered Paper session - NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
1441O - Patient-reported outcomes in cancer patients newly diagnosed with brain metastases
Presenter: Guro Astrup
Session: Proffered Paper session - Supportive and palliative care
Resources:
Abstract
Slides
Webcast
1442O - Proactive early palliative care referral for cancer patients in the intensive care unit: Implementing a novel “triggers” checklist
Presenter: Prakhar Srivastava
Session: Proffered Paper session - Supportive and palliative care
Resources:
Abstract
Slides
Webcast
1488O - Cancer risk in individuals with intellectual disability
Presenter: Qianwei Liu
Session: Proffered Paper session - Supportive and palliative care
Resources:
Abstract
Slides
Webcast
1669O_PR - Late effects, long-term problems, and unmet needs of cancer survivors
Presenter: Martina Schmidt
Session: Proffered Paper session - Supportive and palliative care
Resources:
Abstract
Slides
Webcast
1558O - COVID-19 vaccine in participants (ptcpts) with cancer: Subgroup analysis of efficacy/safety from a global phase III randomized trial of the BNT162b2 (tozinameran) mRNA vaccine
Presenter: Stephen Thomas
Session: Proffered Paper session - SARS-CoV-2 and cancer
Resources:
Abstract
Slides
Webcast
1559O - Efficacy and toxicity of BNT162b2 vaccine in cancer patients
Presenter: Ithai Waldhorn
Session: Proffered Paper session - SARS-CoV-2 and cancer
Resources:
Abstract
Slides
Webcast